The risk of disease progression is determined during the first year of human immunodeficiency virus type 1 infection

被引:43
|
作者
Lefrère, JJ
Roudot-Thoraval, F
Mariotti, M
Thauvin, M
Lerable, J
Salpétrier, J
Morand-Joubert, L
机构
[1] Hop St Antoine, Inst Natl Transfus Sanguine, Virol Lab, F-75571 Paris, France
[2] Hop Henri Mondor, Dept Sante Publ, F-94010 Creteil, France
来源
JOURNAL OF INFECTIOUS DISEASES | 1998年 / 177卷 / 06期
关键词
D O I
10.1086/515308
中图分类号
R392 [医学免疫学]; Q939.91 [免疫学];
学科分类号
100102 ;
摘要
A cohort of 103 human immunodeficiency virus type 1 (HIV-l)-infected persons with well-defined dates of seroconversion were studied to determine whether baseline plasma HIV RNA loads 6-12 months after seroconversion have prognostic value. Baseline plasma virus loads had predictive value for the disease-free survival rate and for the survival rate. The level of baseline HIV RNA also had a strong negative predictive value for the CD4(+) T cell count during the fifth year of infection: A baseline load >5 log was predictive of a CD4(+) T cell count <500/mm(3) 5 years after infection. Baseline HIV RNA load was a CD4(+) T cell-independent predictor of progression to death. The major finding was that the disease outcome for HIV-l-infected persons is already determined during the first year of infection.
引用
收藏
页码:1541 / 1548
页数:8
相关论文
共 50 条
  • [31] Hepatitis c virus load is associated with human immunodeficiency virus type 1 disease progression in hemophiliacs
    Daar, ES
    Lynn, H
    Donfield, S
    Gomperts, E
    O'Brien, SJ
    Hilgartner, MW
    Hoots, WK
    Chernoff, D
    Arkin, S
    Wong, WY
    Winkler, CA
    JOURNAL OF INFECTIOUS DISEASES, 2001, 183 (04): : 589 - 595
  • [32] HLA class I homozygosity accelerates disease progression in human immunodeficiency virus type I infection
    Tang, JM
    Costello, C
    Keet, IPM
    Rivers, C
    LeBlanc, S
    Karita, E
    Allen, S
    Kaslow, RA
    AIDS RESEARCH AND HUMAN RETROVIRUSES, 1999, 15 (04) : 317 - 324
  • [33] Differentiation of human neuroepithelial precursor cells during human immunodeficiency virus type 1 infection
    McCarthy, M
    Auger, D
    Whittemore, SR
    ANNALS OF NEUROLOGY, 2000, 48 (03) : 484 - 484
  • [34] Disseminated histoplasmosis and human immunodeficiency virus type 1 infection: Risk factors in Guatemala
    Segura, L
    Rojas, M
    Pelaez, N
    ShorPosner, G
    RosaRe, D
    Moreno, J
    Klaskala, W
    Baum, MK
    CLINICAL INFECTIOUS DISEASES, 1997, 25 (02) : 343 - 344
  • [35] HUMAN IMMUNODEFICIENCY VIRUS-1 DISEASE PROGRESSION IN HEMOPHILIACS
    BECHERER, PR
    SMILEY, ML
    MATTHEWS, TJ
    WEINHOLD, KJ
    MCMILLAN, CW
    WHITE, GC
    AMERICAN JOURNAL OF HEMATOLOGY, 1990, 34 (03) : 204 - 209
  • [36] Lower High-Density Lipoproteins Levels During Human Immunodeficiency Virus Type 1 Infection Are Associated With Increased Inflammatory Markers and Disease Progression
    Marin-Palma, Damariz
    Castro, Gustavo A.
    Cardona-Arias, Jaiberth A.
    Urcuqui-Inchima, Silvio
    Hernandez, Juan C.
    FRONTIERS IN IMMUNOLOGY, 2018, 9
  • [37] CD4 masking during human immunodeficiency virus type 1 infection, quantified on peripheral blood lymphocytes, is a potential marker of disease progression
    Carriere, D
    Vendrell, JP
    Berthier, AM
    Atoui, N
    Salhi, SL
    Reynes, J
    Gros, P
    Fontaine, C
    Jansen, A
    Huguet, MF
    AitCheik, L
    Pau, B
    JOURNAL OF INFECTIOUS DISEASES, 1996, 173 (03): : 565 - 573
  • [38] Human immunodeficiency virus type 2 infection acquired in Spain with progression to AIDS
    Lorenzo Almoros, Ana
    Vegas, Cesar
    Garcia, Rosa
    Araceli Garcia-Torres, Maria
    ENFERMEDADES INFECCIOSAS Y MICROBIOLOGIA CLINICA, 2014, 32 (05): : 335 - 336
  • [39] Human immunodeficiency virus (HIV) type I antibodies in perinatal HIV-1 infection: Association with human HIV-1 transmission, infection, and disease progression
    Pitt, J
    Henrard, D
    FitzGerald, G
    Mofenson, L
    Lew, J
    Hillyer, G
    Mendez, H
    Cooper, E
    Hanson, C
    Rich, KC
    JOURNAL OF INFECTIOUS DISEASES, 2000, 182 (04): : 1243 - 1246
  • [40] Kinetics of cytokine expression during primary human immunodeficiency virus type 1 infection
    Graziosi, C
    Gantt, KR
    Vaccarezza, M
    Demarest, JF
    Daucher, M
    Saag, MS
    Shaw, GM
    Quinn, TC
    Cohen, OJ
    Welbon, CC
    Pantaleo, G
    Fauci, AS
    PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 1996, 93 (09) : 4386 - 4391